Acetoacetate decarboxylase

From WikiMD's WELLNESSPEDIA

Acetoacetate decarboxylase

Structure of acetoacetate decarboxylase biounit 3BH3

Acetoacetate decarboxylase is an enzyme that catalyzes the decarboxylation of acetoacetate to produce acetone and carbon dioxide. This enzyme plays a crucial role in the ketone body metabolism pathway, particularly in organisms that utilize ketone bodies as an energy source.

Structure[edit]

Acetoacetate decarboxylase is a homotetrameric enzyme, meaning it consists of four identical subunits. Each subunit contains an active site where the decarboxylation reaction occurs. The enzyme's structure is stabilized by interactions between the subunits, which are essential for its catalytic activity.

Active site of acetoacetate decarboxylase

Mechanism[edit]

The catalytic mechanism of acetoacetate decarboxylase involves the formation of a Schiff base intermediate between the substrate, acetoacetate, and a lysine residue in the active site. This intermediate facilitates the release of carbon dioxide, resulting in the formation of acetone.

Mechanism of acetoacetate decarboxylase

Active Site[edit]

The active site of acetoacetate decarboxylase contains several key residues, including lysines, that are critical for its function. These residues participate in substrate binding and catalysis.

Lysines in the active site of acetoacetate decarboxylase

Function[edit]

Acetoacetate decarboxylase is involved in the ketogenesis pathway, where it converts acetoacetate, a ketone body, into acetone. This reaction is important in organisms that rely on ketone bodies as an alternative energy source, such as during prolonged fasting or in diabetic conditions.

Applications[edit]

Understanding the function and mechanism of acetoacetate decarboxylase can have applications in biotechnology and medicine. For example, manipulating this enzyme's activity could potentially influence ketone body levels in metabolic disorders.

Related pages[edit]

Gallery[edit]

Acetoacetate_decarboxylase[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.